Abstract
Artemisinin-based combination therapies (ACTs) have demonstrated in vitro inhibition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). ......
小提示:本篇文献需要登录阅读全文,点击跳转登录